AVANOS MEDICAL, INC. (AVNS) SEC News March 11, 2026, 18:31 UTC 3 1 comments Hurley John Joseph 🔴 sold 226 shares of AVANOS MEDICAL, INC. (AVNS) at $13.29 Transaction Date: Mar 09, 2026 | Filing ID: 000015 Comment Full text
U.S. PHYSICAL THERAPY, INC. (USPH) SEC News March 11, 2026, 18:31 UTC 2 1 comments 📋 Graham Reeve (affiliate) plans to sell 2K shares of U.S. Physical Therapy, Inc. (at $78.76 each, total $155K) Filed: Mar 11, 2026 | ID: 000123 Comment Full text
AVANOS MEDICAL, INC. (AVNS) SEC News March 11, 2026, 18:30 UTC 2 1 comments Galovan Scott Michael 🔴 sold 1.1K shares of AVANOS MEDICAL, INC. (AVNS) at $13.29 Transaction Date: Mar 09, 2026 | Filing ID: 000014 Comment Full text
PACIRA BIOSCIENCES, INC. (PCRX) SEC News March 11, 2026, 18:19 UTC 2 0 comments New Form DEFA14A - Pacira BioSciences, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001628280-26-016906 <b>Size:</b> 198 KB Comment Full text
XBIOTECH INC. (XBIT) SEC News March 11, 2026, 18:14 UTC 2 0 comments New Form S-8 - XBiotech Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001171843-26-001492 <b>Size:</b> 228 KB Comment Full text
ABBVIE INC. (ABBV) SEC News March 11, 2026, 18:01 UTC 2 0 comments New Form 4/A - AbbVie Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0002057696-26-000010 <b>Size:</b> 5 KB Comment Full text
EVOFEM BIOSCIENCES, INC. (EVFM) SEC News March 11, 2026, 17:47 UTC 2 0 comments New Form 10-K - Evofem Biosciences, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001493152-26-009686 <b>Size:</b> 16 MB Comment Full text
IMMUNOCORE HOLDINGS PLC (IMCR) SEC News March 11, 2026, 17:47 UTC 2 1 comments 📋 David Berman (affiliate) plans to sell 12K shares of Immunocure Holdings PLC (at $32.57 each, total $385K) Filed: Mar 11, 2026 | ID: 000121 Comment Full text
INTUITIVE SURGICAL, INC. (ISRG) SEC News March 11, 2026, 17:46 UTC 2 1 comments Curet Myriam 🟡 adjusted position in 105 shares (1 derivative) of INTUITIVE SURGICAL INC (ISRG) at $493.95 Transaction Date: Mar 10, 2026 | Filing ID: 000014 Comment Full text
SAB BIOTHERAPEUTICS, INC. (SABSW) SEC News March 11, 2026, 17:44 UTC 2 0 comments New Form SCHEDULE 13D/A - SAB Biotherapeutics, Inc. <b>Filed:</b> 2026-03-11 <b>AccNo:</b> 0001346824-26-000072 <b>Size:</b> 17 KB Comment Full text